Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Fintech World Post.
Press releases published on June 25, 2025
Getty Realty Corp. to Report Second Quarter 2025 Financial Results
GlobeNewswire
·
June 25, 2025
NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Getty Realty Corp. (NYSE: GTY), a net lease REIT focused on convenience and automotive retail real estate, will release its financial results for the second quarter ended June 30, 2025 after the market closes on …
Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104
GlobeNewswire
·
June 25, 2025
Submission Seeks Approval of GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) Comprehensive Data Package Includes Positive Results from Phase 3 STRIVE-ON Safety Trial of GTx-104 Submission Has the Potential to Trigger …
Soleno Therapeutics Highlights New Data on VYKAT(TM) XR at the 2025 United in Hope: International Prader-Willi Syndrome Conference
GlobeNewswire
·
June 25, 2025
REDWOOD CITY, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today highlighted new data on VYKATTM XR (diazoxide …
Horizon Aircraft Partners with Renowned Designer Andrea Mocellin to Shape the Future of Air Mobility
GlobeNewswire
·
June 25, 2025
TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- New Horizon Aircraft (NASDAQ: HOVR), doing business as Horizon Aircraft (“Horizon Aircraft” or the “Company”), an advanced aerospace engineering company and developer of one the world’s first hybrid eVTOL ( …
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis
GlobeNewswire
·
June 25, 2025
SOUTH SAN FRANCISCO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the IND application submitted by its partner in China, Angel Pharmaceuticals Ltd. ( …
Century Announces Filing of March 31, 2025 Year End Financial Results, Management Discussion and Analysis and Annual Information Form
GlobeNewswire
·
June 25, 2025
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES HONG KONG, June 25, 2025 (GLOBE NEWSWIRE) -- Century Global Commodities Corporation (“Century” or the “Company”) (TSX: CNT) is pleased to announce that it has filed its …
JAKKS Pacific Announces Successful Completion of Debt Refinancing
GlobeNewswire
·
June 25, 2025
SANTA MONICA, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (NASDAQ: JAKK) today announced that on June 24, 2025 it refinanced its existing asset-based revolving credit facility with a new cash flow based first lien secured revolving credit …
Basecamp Research Announces Malawi Biodiscovery Partnership in Series of New Collaborations Across Three Continents at UK Government Nature Action Event
GlobeNewswire
·
June 25, 2025
Partnerships with Malawi, Hungary, and other new partners will rapidly expand BaseData, the largest biological protein database designed specifically for training generative AI foundation models to improve drug discovery and planetary health. …
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
GlobeNewswire
·
June 25, 2025
MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that new pharmacologic and pharmacokinetic in vivo data for investigational oral OPK-88006 tablet treatment …
Asia Broadband Receives Delivery Of Phase 2 Production Line Processing Plant Equipment From China
GlobeNewswire
·
June 25, 2025
LAS VEGAS, June 25, 2025 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has received a major delivery of additional production line processing equipment from China for the new facility …
BioCardia Announces New United States Patent for Helix Biotherapeutic Delivery System
GlobeNewswire
·
June 25, 2025
SUNNYVALE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that the United States Patent Office …
Report: 1 in 2 Employees Have Excessive Privileged Access—CloudEagle.ai Survey Warns of Escalating Insider Risk due to AI and SaaS Sprawl
GlobeNewswire
·
June 25, 2025
PALO ALTO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- A new report from CloudEagle.ai, the AI-powered SaaS management and governance platform, reveals that 60% of enterprise SaaS and AI applications now operate outside IT's visibility. This surge in “ …
ImmuCell Embarks on CEO Succession Planning Process
GlobeNewswire
·
June 25, 2025
PORTLAND, Maine, June 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
GlobeNewswire
·
June 25, 2025
MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that new pharmacologic and pharmacokinetic in vivo data for investigational oral OPK-88006 tablet treatment …
Fangdd Network Group Ltd. Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
GlobeNewswire
·
June 25, 2025
SHENZHEN, China, June 25, 2025 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (NASDAQ: DUO) (“DUO” or the “Company”), today announced that on June 24, 2025, the Company received written notice from the Listing Qualifications Department of The Nasdaq Stock …
Webuy Global Ltd. Named One of Asia-Pacific’s Fastest-Growing Companies by Financial Times
GlobeNewswire
·
June 25, 2025
Singapore, June 25, 2025 (GLOBE NEWSWIRE) -- Webuy Global Ltd. (Nasdaq: WBUY), a technology-driven e-commerce and travel platform, is proud to announce its inclusion in the Financial Times and Statista’s “High-Growth Companies Asia-Pacific 2025” list, …
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
GlobeNewswire
·
June 25, 2025
NEW YORK and STOCKHOLM, Sweden, June 25, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant unmet need, today announced that it …
BIO-key Joins ISMS Forum to Advance Cybersecurity and Identity Management Best Practices in Spain
GlobeNewswire
·
June 25, 2025
MADRID and HOLMDEL, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions, today announced that it has joined ISMS Forum, Spain’s …
ZyVersa Therapeutics Announces Share Purchase Agreement for up to $10 Million in Partnership with Williamsburg Venture Holdings to Fund Clinical Development of Cholesterol Efflux Mediator™ VAR 200
GlobeNewswire
·
June 25, 2025
WESTON, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory diseases who …
Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment
GlobeNewswire
·
June 25, 2025
CMND-100 has the potential to provide an innovative and advanced treatment option for hundreds of millions of people around the world afflicted with Alcohol Use Disorder Vancouver, Canada, June 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: …